ArticleBMC genomics2025
A stacked ensemble classifier for the discovery of prokaryotic efflux proteins based on sequence information.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEfflux proteins (EPs) are key transporters responsible for expelling antibiotics and other harmful substances from bacterial cells, thus contributing significantly to antimicrobial resistance. As such, the development of a reliable and efficient computational method for identifying EPs in bacteria and archaea is of utmost importance. However, current computational methods for EP identification are limited and suffer from various performance and utility constraints.
resultsThis study presents EPDiscovery, a stacking-based ensemble classifier designed to predict prokaryotic EPs directly from their amino acid sequence. EPDiscovery employs the MLP algorithm to integrate the predictions of fifteen baseline classifiers. The test results demonstrated that EPDiscovery accurately identified EPs, achieving AUROC, accuracy, F-value, and Matthews correlation coefficient scores of 0.970, 0.926, 0.927, and 0.852, respectively. Additionally, EPDiscovery outperformed the existing representative method and demonstrated consistent and satisfactory performance, with AUROC scores exceeding 0.9 across three previously proposed datasets. Feature importance analysis using local interpretable model-agnostic explanations further confirmed EPDiscovery's ability to discern the characteristics of EPs from protein sequence information.
conclusionsEPDiscovery offers a reliable alternative for annotating efflux proteins in large-scale bacterial genome studies, thus accelerating the discovery of potential EPs and contributing to the advancement of antimicrobial resistance research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.